KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas

In this study, we examined the clinical significance of KRAS and MAPK1 amplification and assessed whether these amplified genes were potential therapeutic targets in type II ovarian carcinoma. Using fluorescence in situ hybridization, immunohistochemistry, and retrospectively collected clinical data...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rahman, Mohammed Tanjimur, Nakayama, Kentaro, Rahman, Munmun, Katagiri, Hiroshi, Katagiri, Atsuko, Ishibashi, Tomoka, Ishikawa, Masako, Sato, Emi, Iida, Kouji, Nakayama, Naomi, Ishikawa, Noriyuki, Miyazaki, Kohji
Formato: Artigo
Idioma:Inglês
Publicado em: Molecular Diversity Preservation International (MDPI) 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742215/
https://ncbi.nlm.nih.gov/pubmed/23820584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms140713748
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados